炎症性肠病
植物化学
医学
传统医学
炎症性肠病
疾病
内科学
作者
Aya A. Touny,Balaji Venkataraman,Shreesh Kumar Ojha,Mauro Pessia,Veedamali S. Subramanian,Shamanth Neralagundi Harihar gowdru,Sandeep B. Subramanya
出处
期刊:Nutrients
[Multidisciplinary Digital Publishing Institute]
日期:2024-10-25
卷期号:16 (21): 3633-3633
被引量:17
摘要
BACKGROUND/OBJECTIVE: Intestinal fibrosis, a prominent consequence of inflammatory bowel disease (IBD), presents considerable difficulty owing to the absence of licensed antifibrotic therapies. This review assesses the therapeutic potential of phytochemicals as alternate methods for controlling intestinal fibrosis. Phytochemicals, bioactive molecules originating from plants, exhibit potential antifibrotic, anti-inflammatory, and antioxidant activities, targeting pathways associated with inflammation and fibrosis. Compounds such as Asperuloside, Berberine, and olive phenols have demonstrated potential in preclinical models by regulating critical signaling pathways, including TGF-β/Smad and NFκB, which are integral to advancing fibrosis. RESULTS: The main findings suggest that these phytochemicals significantly reduce fibrotic markers, collagen deposition, and inflammation in various experimental models of IBD. These phytochemicals may function as supplementary medicines to standard treatments, perhaps enhancing patient outcomes while mitigating the adverse effects of prolonged immunosuppressive usage. Nonetheless, additional clinical trials are necessary to validate their safety, effectiveness, and bioavailability in human subjects. CONCLUSIONS: Therefore, investigating phytochemicals may lead to crucial advances in the formulation of innovative treatment approaches for fibrosis associated with IBD, offering a promising avenue for future therapeutic development.
科研通智能强力驱动
Strongly Powered by AbleSci AI